Immuron (IMRN) Current Assets (2015 - 2026)
Immuron (IMRN) posted Current Assets of $12.8 million for Q3 2026, up 27.81% on a QoQ basis from $10.0 million in Q4 2025, and up 12728.5% year-over-year from N/an in Q3 2025.
Analysis
Immuron (IMRN) Current Assets (2015 - 2026) Analysis & Trends
Immuron has reported Current Assets for 12 years, with the latest figure at $12.8 million in Q3 2026.
- On a quarterly basis, Current Assets rose 12728.5% year-over-year to $12.8 million in Q3 2026; TTM through Aug 2026 was $12.8 million, a 12728.5% increase from a year earlier, with the FY2026 full-year figure at $12.8 million, up 12728.5% from the prior year.
- Current Assets was $12.8 million for Q3 2026 at Immuron, up from $10.0 million in the prior quarter.
- The five-year high for Current Assets was $17.0 million in Q2 2022, with the low at $98126.7 in Q3 2024.
- Average Current Assets over 5 years is $9.9 million, with a median of $11.4 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2026: Current Assets sank 98.76% in 2023, then jumped 12728.5% in 2026.
- Over 5 years, Current Assets stood at $15.6 million in 2022, then retreated by 14.57% to $13.3 million in 2023, then declined by 27.52% to $9.6 million in 2024, then rose by 4.0% to $10.0 million in 2025, then climbed by 27.81% to $12.8 million in 2026.
- The last three Current Assets figures came in at $12.8 million (Q3 2026), $10.0 million (Q4 2025), and $99780.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | 12.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 12.80 Mn |
| Dec 31, 2025 | 10.02 Mn |
| Sep 2, 2025 | 99,780.03 |
| Jun 30, 2025 | 6.41 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 9, 2024 | 98,126.74 |
| Jun 30, 2024 | 9.71 Mn |
| Dec 31, 2023 | 13.29 Mn |
| Sep 28, 2023 | 13.38 Mn |
| Aug 30, 2023 | 204,093.37 |
| Jun 30, 2023 | 13.64 Mn |
| Dec 31, 2022 | 15.55 Mn |
| Aug 31, 2022 | 16.46 Mn |
| Jun 30, 2022 | 16.96 Mn |
| Dec 31, 2021 | 18.85 Mn |
| Sep 30, 2021 | 18.94 Mn |
| Jun 30, 2021 | 19.83 Mn |
| Dec 31, 2020 | 3.22 Mn |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 2.89 Mn |